It also helps protect cells from further harm by reducing inflammation and defending against microbes. The combination of BPC-157 and TB500 has earned the nickname “the Wolverine stack”, named after ...

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

A Henan University of Science and Technology team reports that boosting miR-542-3p thwarts stress-related cell loss in the ...

The hidradenitis suppurativa (HS) market across the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, ...

Immunoinflammatory skin diseases are characterized by an imbalance in immune homeostasis, and their chronic inflammatory processes involve a complex regulatory network of CD4+ T cell differentiation.

A groundbreaking review in Current Molecular Pharmacology explores the dual roles of Tumor Necrosis Factor-alpha (TNFα) in ...

High-CBD cannabis extract may significantly reduce inflammation and regulate immune activity in rheumatoid arthritis (RA), ...

A new type of drug is being tested and, if successful, it could become the first ever approved to slow or stop aging. The ...

A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

The authors conclude by stating: This study provides the first evidence that CBD inhibits osteosarcoma progression by targeting the TNF-α/NF-κB/CCL5 axis, disrupting a coordinated ...